Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative botulinum toxin injection to improve hair transplantation outcomes in androgenetic alopecia
ChiCTR2400086020Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jun 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of neuronox in androgenetic alopecia (AGA) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Hair count. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
neuronox
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on ChiCTR2400086020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400086020.